ThermoGenesis Announces New Cord Blood Products Distribution Agreements

Published: Sep 19, 2012

RANCHO CORDOVA, Calif., Sept. 19, 2012 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, today said it has signed two additional new channel partner agreements as part of its continuing program to enhance its distribution, technical service and clinical support initiatives of its cord blood products.

Back to news